A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey

Basit Öğe Kaydı
dc.contributor.authorArican, Ali
dc.contributor.authorBozkurt, Tulin
dc.contributor.authorBozcuk, Hakan
dc.contributor.authorDemirkan, Binnaz
dc.contributor.authorBuyukberber, Suleyman
dc.contributor.authorAlkis, Necati
dc.contributor.authorSanli, Ulus Ali
dc.date.accessioned2024-04-24T16:01:55Z
dc.date.available2024-04-24T16:01:55Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractThis study aimed to report the practice of managing breast cancer with bone metastasis in Turkey and to determine the adherence to the British Association of Surgical Oncology (BASO) guidelines. This multicenter, cross-sectional epidemiological survey was conducted in 38 centers across Turkey. Data from 1,026 breast cancer patients with bone metastases (mean age 54.0 +/- 11.9 years) were analyzed. Over 30 % of patients had a diagnosis of metastatic breast cancer (stage IV) at the time of primary diagnosis. The imaging modalities used for diagnosing bone metastases were bone scintigraphy (57.8 %), radiography (22.8 %), and bone survey (4.4 %). Tumor markers were detected in 94.9 %, and markers of bone metabolism were measured in 90.4 % of patients. A total of 3.5 % of patients underwent surgery for bone metastasis, 26.4 % underwent palliative chemotherapy (most commonly docetaxel + capecitabine), and 56.5 % endured radiotherapy. Most patients (96 %) also received bisphosphonate. Radiography, bone scintigraphy, and CT were the main imaging tools used for postoperative follow-up of bone metastasis. Our results were > 95 % in line with the BASO guidelines for the management of bone metastasis, except that interventional procedures, such as biopsy, were applied less frequently in our survey. The diagnosis and management practices of breast cancer with bone metastasis in Turkey were generally compatible with international guidelines. However, the awareness and knowledge of physicians on the current guidelines should be increased, and equipment for the appropriate interventional procedures should be provided in every clinic to obtain optimal and standard management of bone metastases.en_US
dc.description.sponsorshipRoche, Turkeyen_US
dc.description.sponsorshipThis study was financially supported by Roche, Turkey.en_US
dc.identifier.doi10.1007/s00520-014-2253-9
dc.identifier.endpage2634en_US
dc.identifier.issn0941-4355
dc.identifier.issn1433-7339
dc.identifier.issue10en_US
dc.identifier.pmid24752566
dc.identifier.scopus2-s2.0-84933039489
dc.identifier.scopusqualityQ1
dc.identifier.startpage2629en_US
dc.identifier.urihttps://doi.org/10.1007/s00520-014-2253-9
dc.identifier.urihttps://hdl.handle.net/11468/14493
dc.identifier.volume22en_US
dc.identifier.wosWOS:000341713400010
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofSupportive Care in Cancer
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast Neoplasmsen_US
dc.subjectNeoplasmmetastasisen_US
dc.subjectBonesen_US
dc.subjectDiseasemanagementen_US
dc.subjectEpidemiologyen_US
dc.titleA cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkeyen_US
dc.titleA cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu